Clinical Trial Update: Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposomal irinotecan with leucovorin/5-fluorouracil and bevacizumab for metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING